Regional Business Director, Rare Disease - South Central
Boost your chances before you apply.
Alkermes
Dallas, TX, US
Summary
Lead and develop a high-performing sales team to promote sleep medications and exceed sales goals within the South Central region. Develop and execute regional business strategies while building strong partnerships with internal colleagues and external customers.
Job Description
The Regional Business Director (RBD) will be a critical member of the Sales Leadership team, reporting directly to the VP, Sales, and will be responsible for developing and executing the region’s business strategy to deliver the successful promotion of currently approved and potential future sleep medications. Having a customer focused mentality and being able to lead excellence in execution of strategy will be key. Developing strong business focused partnerships with internal colleagues and external customers will be essential for success. This will be accomplished by successfully leading, coaching and developing a diverse, high-performing sales team to exceed sales goals within an assigned geographic area.
Key attributes necessary for success will be the ability to inspire and motivate a high performing, results oriented team, possess a strategic perspective on managing business opportunities and as needed, execute efficient performance management practices.
RBDs must provide clear direction and coaching, work collaboratively in the field with the sales team to assist in identifying needs and opportunities and as needed execute successful sales meetings. In addition, the RBD will establish high work standards and assure that the team works in accordance with all company policies.
Why join Team Alkermes?
Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.
We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders, including addiction, serious mental illness and sleep disorders. With our portfolio of marketed medicines and investigational pipeline candidates, we seek to make a meaningful difference the way people manage these chronic diseases. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized. Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions.
Our core values also guide and define our culture and contribute to our recognition as an employer of choice in the biotech industry.
In 2025, Alkermes was proud to be recognized as:
- A Best Workplace in BioTech and Pharmaceuticals by Fortune Magazine;
- A Top Place to Work in Massachusetts by the Boston Globe;
- A Best Place to Work in Ireland by the Sunday Times Ireland; and
- A Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier
Alkermes is headquartered in Ireland, and also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
Founded
1987
Company size
1,001-5,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Dublin
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders, including addiction, serious mental illness and sleep disorders. With our portfolio of marketed medicines and investigational pipeline candidates, we seek to make a meaningful difference the way people manage these chronic diseases. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized. Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions.
Our core values also guide and define our culture and contribute to our recognition as an employer of choice in the biotech industry.
In 2025, Alkermes was proud to be recognized as:
- A Best Workplace in BioTech and Pharmaceuticals by Fortune Magazine;
- A Top Place to Work in Massachusetts by the Boston Globe;
- A Best Place to Work in Ireland by the Sunday Times Ireland; and
- A Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier
Alkermes is headquartered in Ireland, and also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
Founded
1987
Company size
1,001-5,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Dublin